Skoči na glavni sadržaj

Stručni rad

Neuroleptic malignant syndrome: a case report and discussion

VLATKO GRABOVAC orcid id orcid.org/0000-0002-6796-3691 ; Clinical Hospital Dubrava, Gojko Šušak Avenue 6, 10000 Zagreb, Croatia
SEAD ŽIGA ; Clinical Hospital Dubrava, Gojko Šušak Avenue 6, 10000 Zagreb, Croatia
TATJANA KEREŠ ; Clinical Hospital Dubrava, Gojko Šušak Avenue 6, 10000 Zagreb, Croatia
MAŠA SORIĆ ; Clinical Hospital Dubrava, Gojko Šušak Avenue 6, 10000 Zagreb, Croatia


Puni tekst: engleski pdf 91 Kb

str. 88-90

preuzimanja: 230

citiraj


Sažetak

Neuroleptic malignant syndrome (NMS) is an emergent, life threatening condition most often seen as an iatrogenic complication
of neuroleptic or antipsychotic treatment. It is characterized by a tetrad of clinical features: mental status changes,
fever, muscle rigidity and autonomic instability, although it is not necessary for all of them to be present at a same time for
working diagnosis to be made. This paper will deal with the case of a 29-year old male patient diagnosed with schizophrenia
who developed NMS, presented as a generalized tonic-clonic seizure and high fever, after 191 days of in-hospital treatment.
After 13 days of hospital treatment in the Intensive Care Unit of Clinical Hospital Dubrava, the patient is in a hemodynamical
and proper quantitative mental state and discharged for further psychiatric treatment at his parent hospital institution.

Ključne riječi

neuroleptic malignant syndrome, neuroleptics, creatine kinase

Hrčak ID:

134170

URI

https://hrcak.srce.hr/134170

Posjeta: 604 *